Whitepapers/App Notes/Posters

Technical note: The content of nevirapine and related impurities

Posted: 14 December 2021 | | No comments yet

Guidance on generating an intelligent, automated workflow for batch-release analysis of an active pharmaceutical ingredient (API).

In both R&D and QC pharmaceutical laboratories, determining the content of an active pharmaceutical ingredient and its related impurities are typical analyses.

While it is common to apply different methods for assay and impurity determination for one API, in practice it is preferred to combine both analyses into one single run. Automated data processing and reporting allows for a quick, reliable data evaluation and documentation, as it is required in the pharmaceutical regulated environment.












    To read this technical note in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Thermo Fisher Scientific

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Send this to a friend